Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Prognostic value of apoptotic index in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004
Prognostic factors in non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002
Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
Prognostic value of smoking status in operated non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004
Prognostic significance of Nestin in resected non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
Prognostic parameters in non-small cell lung cancer (211 cases) Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002
Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004
Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010
Prognostic factors for non-small cell lung cancer: an analysis of last decade Source: Eur Respir J 2005; 26: Suppl. 49, 325s Year: 2005
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005